BibTex format
@article{Chalmers:2023:10.1183/23120541.00633-2022,
author = {Chalmers, JD and Gupta, A and Chotirmall, SH and Armstrong, A and Eickholz, P and Hasegawa, N and McShane, PJ and O'Donnell, AE and Shteinberg, M and Watz, H and Eleftheraki, A and Diefenbach, C and Sauter, W},
doi = {10.1183/23120541.00633-2022},
journal = {ERJ OPEN RESEARCH},
title = {A Phase 2 randomised study to establish efficacy, safety and dosing of a novel oral cathepsin C inhibitor, BI 1291583, in adults with bronchiectasis: Airleaf},
url = {http://dx.doi.org/10.1183/23120541.00633-2022},
volume = {9},
year = {2023}
}
RIS format (EndNote, RefMan)
TY - JOUR
AU - Chalmers,JD
AU - Gupta,A
AU - Chotirmall,SH
AU - Armstrong,A
AU - Eickholz,P
AU - Hasegawa,N
AU - McShane,PJ
AU - O'Donnell,AE
AU - Shteinberg,M
AU - Watz,H
AU - Eleftheraki,A
AU - Diefenbach,C
AU - Sauter,W
DO - 10.1183/23120541.00633-2022
PY - 2023///
TI - A Phase 2 randomised study to establish efficacy, safety and dosing of a novel oral cathepsin C inhibitor, BI 1291583, in adults with bronchiectasis: Airleaf
T2 - ERJ OPEN RESEARCH
UR - http://dx.doi.org/10.1183/23120541.00633-2022
VL - 9
ER -